BROOKE STOKES: Open Payments
NPI 1265752778 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 36 payments from 14 companies in 2025. Trend: 2023 $1,367 · 2024 $780 · 2025 $846
Food & beverage: $747Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $356 |
| Sage Therapeutics, LLC | 4 | $95 |
| Evofem Biosciences, Inc. | 5 | $77 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 2 | $54 |
| Exeltis, USA Inc. | 2 | $36 |
| MILLICENT US INC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: Veozah, ZURZUVAE, Phexxi, MYFEMBREE, Qelbree, SLYND, Mirena, BD Onclarity.
Industry payments across LA — which companies pay providers there.
